Screening or prevention measure | Percentage of patients in agreement with screening/management recommendation at baseline assessment | Percentage of patients in agreement with screening/management recommendation at 3-year follow-up | P value between baseline and follow-up |
CV risk assessment | |||
Blood pressure measurement | 64.0 | 96.2 | <0.0001 |
Fasting blood glucose measurement | 53.6 | 67.4 | <0.0001 |
Lipid measurement | 49.8 | 65.2 | <0.0001 |
Creatinine measurement | 77.8 | 94.5 | <0.0001 |
Cancer screening | |||
Colon/rectum | 50.3 | 49.7 | 0.19 |
Skin | 57.9 | 79.7 | <0.0001 |
Prostate | 78.7 | 74.8 | 0.34 |
Breast | 68.8 | 72.2 | 0.29 |
Cervix | 63.8 | 63.4 | 0.94 |
Vaccination | |||
Influenza | 44.1 | 54.7 | <0.0001 |
Pneumococcus | 59.9 | 65.3 | <0.01 |
Osteoporosis screening | |||
Bone densitometry | 74.4 | 88.0 | <0.0001 |
The percentages are all percentage of patients in conformity with the screening/prevention guidelines (as presented in table 1), among patients at risk (eg, in the age and gender group at risk and without previous presence of the comorbidity).
CV, cardiovascular.